Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Pyridam Farma Tbk (PYFA) vs Summarecon Agung Tbk. (SMRA) Price & Performance

Pyridam Farma TbkTrade
Summarecon Agung Tbk.Trade

Price performance (Past 24H)

Key statistics

Pyridam Farma Tbk vs Summarecon Agung Tbk. — how do they compare? Pyridam Farma Tbk trades at Rp216 (market cap 2.38T, 3.37M 24h volume), while Summarecon Agung Tbk. trades at Rp328 (market cap 5.38T, 5.52M 24h volume). The key difference: Summarecon Agung Tbk. is far larger — about 2.3× Pyridam Farma Tbk's market cap, and Summarecon Agung Tbk. is more actively traded (5.52M versus 3.37M). Which is the better fit depends on your goals.

PYFASMRA
Market Cap
2.38T5.38T
Volume
3.37M5.52M
Lot
33.75K55.21K
Turnover
717.36M1.81B
Average Price
212.56327.64
Value
717.36M1.81B
Indicative Equilibrium Price
216328
Indicative Equilibrium Volume
315199

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

PYFA
View details
SMRA
View details

About Pyridam Farma Tbk

PT. Pyridam Farma Tbk. Founded in Jakarta based on Limited Company Act on November 27th 1976 and start the commercial operation since 1978 which conduct in pharmaceutical business.On its first establishmnent, the corporate produce & distribute medicine products for livestock & pet.. Since 1985 the corporate develop pharmacy division which emphasize produce and distribute health product for human and for livestock held by veterinary division.

Read more on PYFA

About Summarecon Agung Tbk.

PT Summarecon Agung Tbk (the Company) was established within the framework of the Domestic Capital Investment Law based on notarial deed No. 308 dated November 26, 1975 of Ridwan Suselo, S.H. PT. Summarecon Agung Tbk is one of the nation`s leading township developers. Entering its twenty-forth year, the original 10-hectare landbank it started with has turned into a vibrant, 500 hectare township in North Jakarta where commercial vivacity peacefully coexists with its houses numbering in the tens of thousands.

Read more on SMRA